Oleyl myristate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591245

CAS#: 22393-93-7

Description: Oleyl myristate is a bioactive chemical.

Chemical Structure

img
Oleyl myristate
CAS# 22393-93-7
Instruction

Theoretical Analysis

MedKoo Cat#: 591245
Name: Oleyl myristate
CAS#: 22393-93-7
Chemical Formula: C32H62O2
Exact Mass: 478.48
Molecular Weight: 478.850
Elemental Analysis: C, 80.27; H, 13.05; O, 6.68

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Oleyl myristate;

IUPAC/Chemical Name: Myristic acid, 9-octadecenyl ester, (Z)-

InChi Key: WMOBLRURFXZUMY-MSUUIHNZSA-N

InChi Code: InChI=1S/C32H62O2/c1-3-5-7-9-11-13-15-16-17-18-19-21-23-25-27-29-31-34-32(33)30-28-26-24-22-20-14-12-10-8-6-4-2/h16-17H,3-15,18-31H2,1-2H3/b17-16-

SMILES Code: CCCCCCCCCCCCCC(OCCCCCCCC/C=C\CCCCCCCC)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 478.85 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Fan J, Liu F, Wang Z. Shear rheology and in-vitro release kinetic study of apigenin from lyotropic liquid crystal. Int J Pharm. 2016 Jan 30;497(1-2):248-54. doi: 10.1016/j.ijpharm.2015.12.008. Epub 2015 Dec 4. PubMed PMID: 26657272.

2: Alsaqr A, Rasoully M, Musteata FM. Investigating transdermal delivery of vitamin D3. AAPS PharmSciTech. 2015 Aug;16(4):963-72. doi: 10.1208/s12249-015-0291-3. Epub 2015 Jan 22. PubMed PMID: 25609377; PubMed Central PMCID: PMC4508301.

3: Yamanaka M, Yokota S, Iwao Y, Noguchi S, Itai S. Development and evaluation of a tacrolimus cream formulation using a binary solvent system. Int J Pharm. 2014 Apr 10;464(1-2):19-26. doi: 10.1016/j.ijpharm.2014.01.017. Epub 2014 Jan 20. PubMed PMID: 24456671.

4: Lee KE, Choi YJ, Oh BR, Chun IK, Gwak HS. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems. Int J Pharm. 2013 Nov 18;456(2):432-6. doi: 10.1016/j.ijpharm.2013.08.044. Epub 2013 Sep 2. PubMed PMID: 24008082.

5: Bousquet SM, Monet M, Boulay G. Protein kinase C-dependent phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine 448 causes channel inhibition. J Biol Chem. 2010 Dec 24;285(52):40534-43. doi: 10.1074/jbc.M110.160051. Epub 2010 Oct 20. PubMed PMID: 20961851; PubMed Central PMCID: PMC3003352.

6: El-Setouhy DA, El-Ashmony SM. Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety. J Pharm Pharmacol. 2010 Jan;62(1):25-34. doi: 10.1211/jpp.62.01.0002. PubMed PMID: 20722996.

7: Pietkiewicz J, Zielińska K, Saczko J, Kulbacka J, Majkowski M, Wilk KA. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Eur J Pharm Sci. 2010 Mar 18;39(5):322-35. doi: 10.1016/j.ejps.2009.12.012. Epub 2010 Jan 7. PubMed PMID: 20060468.

8: Shevachman M, Garti N, Shani A, Sintov AC. Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion. Drug Dev Ind Pharm. 2008 Apr;34(4):403-12. doi: 10.1080/03639040701662479 . PubMed PMID: 18401782.

9: Lee PJ, Ahmad N, Langer R, Mitragotri S, Prasad Shastri V. Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm. 2006 Feb 3;308(1-2):33-9. PubMed PMID: 16321488.

10: Matsui R, Hasegawa M, Ishida M, Ebata T, Namiki N, Sugibayashi K. Skin permeation of lidocaine from crystal suspended oily formulations. Drug Dev Ind Pharm. 2005 Sep;31(8):729-38. PubMed PMID: 16221607.

11: Deswal R, Chowdhary GK, Sopory SK. Purification and characterization of a PMA-stimulated kinase and identification of PMA-induced phosphorylation of a polypeptide that is dephosphorylated by low temperature in Brassica juncea. Biochem Biophys Res Commun. 2004 Sep 17;322(2):420-7. PubMed PMID: 15325246.

12: Osuna L, Coursol S, Pierre JN, Vidal J. A Ca(2+)-dependent protein kinase with characteristics of protein kinase C in leaves and mesophyll cell protoplasts from Digitaria sanguinalis: possible involvement in the C(4)-phosphoenolpyruvate carboxylase phosphorylation cascade. Biochem Biophys Res Commun. 2004 Feb 6;314(2):428-33. PubMed PMID: 14733923.

13: McHugh D, Sharp EM, Scheuer T, Catterall WA. Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12334-8. PubMed PMID: 11035786; PubMed Central PMCID: PMC17342.

14: Chandok MR, Sopory SK. ZmcPKC70, a protein kinase C-type enzyme from maize. Biochemical characterization, regulation by phorbol 12-myristate 13-acetate and its possible involvement in nitrate reductase gene expression. J Biol Chem. 1998 Jul 24;273(30):19235-42. PubMed PMID: 9668112.

15: Sun QY, Wang WH, Hosoe M, Taniguchi T, Chen DY, Shioya Y. Activation of protein kinase C induces cortical granule exocytosis in a Ca(2+)-independent manner, but not the resumption of cell cycle in porcine eggs. Dev Growth Differ. 1997 Aug;39(4):523-9. PubMed PMID: 9352207.

16: Straarup EM, Schousboe P, Hansen HQ, Kristiansen K, Hoffmann EK, Rasmussen L, Christensen ST. Effects of protein kinase C activators and staurosporine on protein kinase activity, cell survival, and proliferation in Tetrahymena thermophila. Microbios. 1997;91(368-369):181-90. PubMed PMID: 9523425.

17: Park RW, Kim IS, Jo JS. Bisindolylmaleimide inhibits the PMA-induced down-regulation of collagen synthesis in fibroblasts. Biochem Mol Biol Int. 1996 Sep;40(1):101-9. PubMed PMID: 8886275.

18: Törnquist K, Pasternack M, Kaila K. Sphingosine derivatives inhibit depolarization-evoked calcium entry in rat GH4C1 cells. Endocrinology. 1995 Nov;136(11):4894-902. PubMed PMID: 7588222.

19: Hohage H, Löhr M, Querl U, Greven J. The renal basolateral transport system for organic anions: properties of the regulation mechanism. J Pharmacol Exp Ther. 1994 May;269(2):659-64. PubMed PMID: 8182533.

20: Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994 Mar;266(3 Pt 2):H1145-52. PubMed PMID: 8160817.